Seroprevalence of dengue virus among children presenting with febrile illness in some public health facilities in Cameroon

Seroprevalence of dengue virus among children presenting with febrile illness in some public health facilities in Cameroon

Salomon Bonsi Tchuandom^1,2, Thibau Flaurant Tchouangueu^1,3, Christophe Antonio-Nkondjio⁴, Abel Lissom⁵, Jean Olivier Ngono Djang², Etienne Philemon Atabonkeng¹, Assumpta Kechia⁶, Godwin Nchinda³, Jules-Roger Kuiate^1,&

 

¹Department of Biochemistry, University of Dschang, Cameroon, ²Public School of medical Laboratory Technicians, Yaoundé, Cameroon, ³Laboratory of Microbiology and Immunology, Chantal Biya International Reference Centre for Research and Prevention on HIV/AIDS Yaoundé, ⁴Laboratoire de Recherche sur le Paludisme, Organisation de Coordination pour la lutte Contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroun, ⁵Department of Animal Biology and Physiology, University of Yaoundé 1, Yaoundé, ⁶Ministry of Public Health, Yaoundé, Cameroun

 

 

^&Corresponding author
Jules-Roger Kuiate, Department of Biochemistry, University of Dschang, Cameroon

 

 

 

 

Dengue is a tropical disease transmitted by mosquitoes of the genus Aedes [1, 2]. Infection by dengue virus causes flu-like illness and can occasionally develop to severe complications and death. Dengue has grown dramatically over the years and it is estimated that about half of the world population is now at risk [3]. Dengue is a leading cause of serious illness and death among children in Asia and Latin America [3]. Yet the real number of dengue cases is underreported and many cases are misclassified [3]. In Africa, at least 15 countries declared locally acquired dengue cases since 1960. Moreover, dengue has frequently been detected in travellers returning from over 30 African countries. In Central African region, dengue is highly prevalent and cases of dengue infection have been reported in recent dengue-like symptoms outbreaks in Cameroon and Gabon [4-6]. A study conducted in three major towns in Cameroon by Demanou et al. [6], reported dengue virus IgM seroprevalence of 0.3, 0.1 and 0.0% among healthy children in Douala, Garoua and Yaounde respectively but no known study has described DENV IgM seroprevalence among febrile children in Cameroon. WHO gives priority to malaria when considering the aetiology of fever in tropical countries [7].

It is therefore recommended to think of malaria diagnosis in the first place when feverish syndromes are observed in patients with empirical treatment of malaria administered in sufficient dose and duration. Like malaria or enteric fever, dengue infection symptoms include fever headache, rash, vomit and joint pain [8, 9]. Fever accounts for 70% of purposes of consultation for children visiting health care facilities in Cameroon [10]. More than 80% of primary infection of dengue virus in children are usually asymptomatic and are generally characterized by a fever greater than 38°C in addition to other symptoms identical to those of malaria or enteric fever [11, 12]. A particular feature for dengue fever is that its re-infections can be associated with haemorrhage or shock syndromes in patients [2, 6, 12-19]. Children under the age of 15 are particularly at risk of developing a severe form of dengue fever (DF) as well as any patient who had already been infected by another serotype of the virus [20]. Most arboviruses especially DENV are rarely taken into consideration by local clinicians because the disease is not considered as endemic and the diagnosis is always focused on other endemic diseases such as enteric fever and malaria. However, early diagnosis of DF by a rapid diagnostic test for the detection of immunoglobulin M (IgM) and non-structural protein 1 (NS1) is important for preventing potential complications in children [21, 22] and also to limit the over-consumption of anti-malarial drugs and antibiotics by patients who do not need them. This could also help in slowing down the development and emergence of resistance to antibiotics and antimalarial drugs.

 

 

Study design: this study was carried out in 10 public health facilities located in the Adamaoua, Center, Far North, Littoral and West regions of Cameroon. These health care centre are tertiary health facilities serving the low, middle and high income patients. The official languages spoken are French and English.

 

Research design: this was a cross-sectional multicentric study performed to determine the seroprevalence of dengue virus infection among children presenting with undifferentiated fever in some public health facilities in Cameroon. The study was conducted from March 2016 to April 2017. In absence of data on DENV exposure rates among children attending health facilities with febrile illness in Cameroon, maximum possible proportion was considered to be 0.5 based on [23] and the required sample size calculated to be 384. The study included 961 children aged 0-15 years randomly selected from health facilities. Systematic random sampling was employed by selecting after every third child. Children included in this study were febrile (temperature ≥38°C) with at least one of specific symptoms (fever, headache, rash, vomit and joint pain), aged 4 months to 15 years regardless of gender, ethnicity or tribe. However, we excluded children admitted at the hospital for known diseases or with fever more than seven days.

 

Description of study sites: the study was conducted in ten areas (five semi-urban and five urban) including Kaelé, Bankim, Ntui, Bafia, Edéa, Yaoundé, Douala, Bangangte, Foumban, Dschang. The populace are predominantly traders, house wives and students. The map was constructed using the software ArcGIS® version 10.2 and the field coordinates were obtained with the help of GPS etrex 20X (Garmin®) as shown on Figure 1. Kaele (10° 06' 00"N, 14° 27' 00" E): is a semi-urban city located in a dry savanna or sudano-sahelian zone characterized by a long dry season of about eight months, (October to May) and a short rainy season of four months (June to September). The average annual rainfall and temperature are 809mm 28.1°C respectively. The health district of Kaele covers a population of 126,376 inhabitants from 90 villages.

 

Bankim (6° 00' 00" N, 11o 40' 00" E): is a semi-urban city located in a wet savanna zone characterized by 5 months of dry season and 7 months of rains with an annual rainfall of 1200mm. The health district of Bankim cover 43 villages for a total population of 50,000 inhabitants. Bangangte (5° 09'00"N, 10° 31' 00" E), Foumban (5° 43' 00" N, 10° 55' 00" E) and Dschang (5° 23' 00" N, 10° 10" 00" E): are urban cities all located in the high mountain area of western Cameroon. The area exhibits, a sub-tropical climate characterized by two seasons; one dry season of 4 months and one rainy season of 8 months. Annual average rainfall and temperature are of 321 mm and 21.6°C respectively). The health district of Bangangte covers 91 villages for a population of 63,595 inhabitants, Foumban health district cover 15 villages for a total of 152,728 inhabitants and Dschang health district cover 11 villages for a total of 101,385 inhabitants.

 

Ntui (4° 26' 59.99" N, 11° 37' 59.99" E), Bafia (4° 45' 00" N, 11° 14' 00" E), Yaoundé (03° 50' 00" N, 11° 31' 00" E) and Edéa (03° 48' 00" N, 10° 08' 00" E) are all located in the equatorial forest zone characterized by four seasons including 2 rainy seasons and 2 dry seasons. The climate is equato-Guinean (with average annual rainfall ranging from 1200 to 3300mm). Ntui is a semi-urban city whereas Bafia, Yaoundé and Edéa are all urban areas. The health district of Ntui covers 27 villages for a total population of 20, 000 inhabitants, Bafia cover 8 villages for a total population of 55,506 inhabitants and Yaoundé the capital of Cameroon has a population of 2,765,568 inhabitants with many reference health centres [24]. Douala (04° 03' 8.1" N, 09° 45' 42.94" E): is an urban area located in the coastal zone characterized by two seasons (01 dry (03 months), 01 humid (9 months of rain). The climate is monsoon humid (average annual precipitation and temperature of 4000 mm of rain per year and 28°C respectively). Douala is the economic capital and has a population of 2,768,436 inhabitants with many reference health care centres [24].

 

Ethical consideration: this study received ethical approval from the Cameroonian National Ethics Committee for Research on Human Subjects, Ethical Clearance number N° 2014/12/530/CE/CNERSH/SP in accordance with the Helsinki declaration by the World Medical Association (WMA) on the ethical principles for medical research involving human subjects [25]; after which the subject were served questionnaires.

 

Patient information and informed consent: the risks, if any and benefits of the study participation were explained to the patient during the administration of informed consent. Written consent was obtained from the parents or guardians or legal representative. In case of patients between 10-14 years, assent was also obtained.

 

Blood sampling: two millilitres(2ml) of venous blood was collected by venipuncture from children and dispensed in EDTA tubes and centrifuged at 4000 rpm for 10 min for rapid diagnostic test of enteric fever, malaria, dengue markers (IgM) and IgM ELISA assay. The plasma fraction was collected, aliquoted in small, single used volumes and stored for at -20° for subsequent analyses.

 

Detection of enteric fever: The diagnosis of enteric fever was done using SD Bioline Typhoid (Standard Diagnostics, Kyyonggi-do, Korea) method to qualitatively detect IgM and IgG antibodies to serotype Typhi antigens (unspecified). The presence of specific antibodies was revealed by the appearance of red line in the test zone (T) and control zone (C) of the assay device (Figure 1).

 

Detection of plasmodium spp for malaria infection: rapid malaria antigen test (SD BIOLINE Pf/Pan test, Biostandard Diagnostic LTD, Gurgaon, India) was done using qualitatively differential method for detecting parasite dehydrogenase (pLDH) pan specific to Plasmodium spp (P. vivax, Plasmodium ovale and Plasmodium malariae) and histidine rich protein II (HRP-II) specific to Plasmodium falciparum. The presence of Plasmodium spp was revealed by the appearance of red line in the test zone (T) and control zone (C) of the assay device.

 

Detection of dengue virus (dengue fever): infection to DENV was assessed using a rapid diagnostic test detecting IgM antibodies in the plasma of participants using tell me fast® Dengue IgG/IgM antibody Combo test (Biocan Diagnostics Inc. Canada). Interpretation of the results was done in conformity to the manufacturer's instructions and the presence of DENV markers was revealed by the appearance of red line in the test zone (T) and control zone (C) of the assay device.

 

DENV characterization using ELISA: DENV infection was confirmed in participants using an in-house indirect ELISA (Unpublished). To characterize the specific DENV serotypes, a quantity of 50 ng/well of each of rDengue antigen D1,D2, D3 and D4 envelopes (recombinant protein in E. coli, purchase from ImmunoDX, LLC, Woburn, USA), were added to high binding 96-well flat bottom microsorp (Thermo Fisher Scientific) ELISA plates and incubated overnight at 4^oC. The following day, plates were washed 3x with PBST (PBS with 0.05 % Tween-20) and blocked either with 3% BSA or 1x Roti block (Carl ROTH, Karlsruhe, Germany) for one hour at 37°C. Plasma samples diluted at 1/200 in 2% BSA containing-PBS, then 100 µl of the diluted antibodies were added per well of the blocked ELISA plates and incubated for two hours at 37°C. Unbound antibody was removed by washing the plates 5x (198 µl/well) with PBST. Horseradish Peroxidase (HRP) coated mouse anti-human IgG Fc (Clone JDC-10) and mouse anti-human IgM (Clone SA-DA4) antibodies (Southern Biotech, Birmingham, USA) diluted 1:4000 in 0.1x roti block (100 µl/well) were introduced. Bound conjugate was detected using ABTS One Component Microwell Substrate (Southern Biotech) and the HRP reaction stopped by adding 50 µl of a stop (Sulfuric acid, 4N) solution according to the manufacturer's protocol (Southern Biotech). The optical density was measured at 405 nm using a multiskan FC microplate reader (Thermo Fisher Scientific, USA). The sample diluent was used as a negative control. The threshold of detection was calculated as the highest OD of background + 2.5 SD of background ODs. Samples with ODs greater than the threshold were considered positive.

 

Statistical analysis: tabulation, management, and analysis of raw data were carried out using Microsoft Excel (Microsoft Inc., Redmond, WA). Statistical analysis was performed with statistical package for social sciences (SPSS) software (version 22.1). The mean, frequencies and percentages were used to summarize descriptive statistics of the data. Chi-square (x²) test was used to assess relationships between selected and/or categorical variables namely gender, sex, semi-urban and urban areas. The binomial tests were used to determine the statistical discrepancy of dengue virus positive children in malaria positive and malaria negative. Odds ratios were determined from contingency tables using the Fisher's exact test to assess the level of association between dengue exposure cases and dependent variable such as age, sex or sites characteristics. The level of significance will be set at p<0.05.

 

 

Characteristics of study populations: a total of 961 consenting children attending hospital for febrile illness and for whom the clinician suspected malaria and/or typhoid fever were included in the study. The minimum number of children recruited per site was 60 in Bafia and the highest was 150 in both Kaele and Bankim (Table 1). According to gender there were more males (51 .5%) compared with females (48.5%), with a general age mean (±SD) 7.1±2.9 years [4 months-15 years]. Majority (48.8%) of the children were between the ages of 1-5 years, followed by those aged 5-15 years (43.8%). Those age 4-11 months had the least percentage (7.4%) (Table 1).

 

Prevalence of different infections: out of the 961 children examined, 138 (14.36%) were positive for dengue virus IgM and 390 (40.6%) had evidence of malaria parasite infection. Plasmodium falciparum was the most frequent species identified (377/390). Other Plasmodium spp accounted for 14.4% (13/390) of Plasmodium infections. DENV specific antibodies were detected in individuals from all study sites with Bankim, Yaoundé and Dschang, having the highest exposure rates (Table 2). A high prevalence of malaria was recorded in Douala, Edea and Bafia whereas low infection rate was recorded in Kaele where transmission is seasonal (Table 2). Seropositivity rates for each infection tested differ according to sites. The diagnosis of enteric fever detected 22 (2.3%) infection cases. The pathogenic agents detected could be Salmonella typhi or Salmonella paratyphi (Table 2). Out of 961 children, 40 (4.2%) and 6 (0.6%) cases of co-infections for malaria and dengue or malaria and typhoid were detected respectively. Pattern of clinical signs among febrile illness shows association between clinical signs (joint pain and fatigue) and sero-positivity to dengue (p<0.0001) (Table 3). Table 4 summarizes the co-infection of dengue virus and malaria status among febrile illness. More (18.42%) of negative malaria children were dengue virus positive, while a lower but not significant percentage (8.44%) of positive malaria children were dengue virus positive (p=0.075). No significant association was detected between seropositivity and exposure to DENV and categorical variables (age, sex, collection sites) (Table 5).

 

 

Dengue virus is an important emerging disease of the tropical and sub-tropical country today. The differential diagnosis associated with dengue fever includes a wide variety of parasitic and bacterial infections that produce similar syndrome. This study investigated the seroprevalence of dengue among children presenting with undifferentiated fever who are living in ten areas of Cameroon. Laboratory diagnosis of acute infection (dengue, enteric fever or malaria) is important to provide appropriate treatment and to reduce development and emergence of resistance to antibiotics and antimalarial drugs. In malaria endemic areas like in Cameroon, most febrile illnesses are treated as malaria or enteric fever cases due to lack of trained staff and laboratory to properly rule-out malaria or enteric fever as a cause of fever and as well, identify alternative fever-causing pathogens [14, 26, 27]. Diagnosis of dengue in children based on clinical presentation is difficult as for enteric fever or malaria even if results in this study reported associations between clinical signs with most tropical diseases. The prevalence of malaria was highest, about 41% of the children complaining for fever attending hospital were really suffering from malaria. This is consistent with the actual situation of the disease in the country [24]. Plasmodium falciparum was the main species detected in all malaria cases. It is rather possible that a high proportion of children complaining of fever detected as negative could be suffering from malaria since the consumption of antimalarial drugs when suffering from fever before attending health care facilities have been reported to be high in the population [28]. We report 5.3% (51/961) cases of dengue with acute malaria, concurrent infections of dengue and malaria data in Cameroon are scarce. The prevalence of enteric fever (Salmonella typhi and Salmonella paratyphi A) appeared to be low in children at the different geographical settings and is in conformity with studies reported in Cameroon by Nsutebu et al [14].

 

We determined an overall prevalence of 14.4% (138/961) of dengue among children with febrile illness in both urban and semi-urban areas. This finding is in contrast to the study carried out by Chukwuma et al. [29] who investigated the seroprevalence of dengue virus among children with febrile illness in Nnewi (Nigeria) and reported a prevalence rate of 77.1%. Again, the study carried out by Onoja et al. [30] who explored the high rate of unrecognized dengue virus infection in parts of the rainforest region of Nigeria and found a prevalence rate of 23.3%. Dengue virus IgM seroprevalence among febrile children is scarcely documented in Cameroon. However, 14.8% prevalence among children under 6 years of age agrees with a study involving in the same age group of children in Llorin, North central and in parts of the rainforest region of Nigeria, were high prevalence was reported [30, 31]. We observed few positive cases to dengue IgM (7%, 16% and 14% respectively) among the various age group of children febrile illness (less than 1 year, 1-5 years and 6-15 years old respectively). According to WHO recommendations [32], the diagnosis of dengue virus can be confirmed when at least IgM is positive during seroconversion in paired sera. As previously reported in some studies [4, 6, 8, 33] dengue is endemic in Cameroon but this study is the first carried out among children with febrile illness. Dengue virus IgM biomarkers were detected in all age groups. This suggests that children were recently bitten by Aedes mosquitoes during the day. However, several authors suggested transmission of antibodies or Dengue virus from mother to child through breastfeeding [34-36].

 

Transmission of DENV in several semi-urban and urban regions (Figure 1) is an indication that it is widespread in urban and semi-urban populations. Human-DENV-Mosquito cycle has been reportedly found in nearly all urban and semi-urban environments throughout the tropics and subtropics [37]. Dengue in tropical and subtropical regions has increased due to uncontrolled urbanization, lack of effective and sustainable vector control programs [38]. Although the serotype(s) involved in this children is/are not known, all DENV serotypes involved in urban and semi-urban dengue cycle are transmitted by domestic and peri-domestic Aedes aegypti and Aedes albopictus [20, 38-40]. These Aedes spp circulates steadily in Cameroon since 1984 [1, 41-48]. The seroprevalence of the dengue virus in the hospital centers included in this study was low. However, a more representative sampling, in number and spatial distribution of health centers in the Cameroonian territory would allow a more realistic prevalence. Also, the direct diagnosis by RT-PCR could show us the circulating serotypes and strains of the dengue virus in the study environment.

 

 

We have reported seroprevalence of dengue virus in fever illness children, from some health facilities in Cameroon for the first time. Our study has revealed that dengue prevalence is low in children presenting with febrile illness in Cameroon. However, getting a realistic prevalence would demand a more representative sample size (numbers and multiple health facilities). Nevertheless, with this study, it has become more evident that routine dengue testing should be done in febrile illnesses children and may be adults in the hospitals of Cameroon to avoid being surprised by an epidemic due to inadequate patient follow-up. In addition, further research to determine acute fever due to dengue infection, the circulating serotypes and strains of the virus in the study environment are warranted.

 

 

The authors declare no competing interests.

 

 

Salomon Bonsi Tchuandom, Godwin Nchinda and Jules-Roger Kuiate Conceived the study. All the authors data collection and prepared manuscript. Salomon Bonsi Tchuandom, Thibau Flaurant Tchouangueu, Christophe Antonio-Nkondjio, Abel Lissom, Godwin Nchinda and Jules-Roger Kuiate Drafted the scientific manuscript. All authors read and approved the final manuscript.

 

 

The authors would like to thank all hospitals for the administrative authorization. Our special thanks and appreciation also go to all the study participants who voluntarily participated in this study. They also thank the personnel of the International Reference Centre "Chantal Biya" for research on the prevention and management of HIV/AIDS (ICRW) for the consistent support with some reagents and other materials during this work. Special thanks go to Miss Rachel Siliki Mbassa for the statistical analysis.

 

 

Table 1: demographic characteristics of the children with febrile illness according to sites characteristics

Table 2: prevalence of different infections in study sites

Table 3: pattern of clinical signs among febrile illness

Table 4: co-infection of dengue virus and malaria among febrile illness

Table 5: odds of seropositivity according to age, sex and sites characteristics

Figure 1: map of Cameroon: location of the 10 study sites

 

 

1. Kamgang B, Happi JY, Boisier P, Njiokou F, Herve JP, Simard F et al. Geographic and ecological distribution of the dengue and chikungunya virus vectors Aedes aegypti and Aedes albopictus in three major Cameroonian towns. Med Vet Entomol. 2010; 24(2): 132-41. PubMed | Google Scholar


2. Krippner R, von Laer G. First confirmed dengue-1 fever cases reported from Cameroon. J Travel Med. 2002; 9(5): 273-4. PubMed | Google Scholar


3. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL et al. The global distribution and burden of dengue. Nature. 2013; 496(7446): 504-7. PubMed | Google Scholar


4. Peyrefitte CN, Rousset D, Pastorino BA, Pouillot R, Bessaud M, Tock F et al. Chikungunya virus, Cameroon, 2006. Emerging Infect Dis. 2007; 13(5): 768-71. PubMed


5. Nkoghe D, Kassa RF, Bisvigou U, Caron M, Grard G, Leroy EM. No clinical or biological difference between Chikungunya and Dengue Fever during the 2010 Gabonese outbreak. Infect Dis Rep. 2012; 4(1): e5. PubMed | Google Scholar


6. Demanou M, Pouillot R, Grandadam M, Boisier P, Kamgang B, Herve JP et al. Evidence of dengue virus transmission and factors associated with the presence of anti-dengue virus antibodies in humans in three major towns in cameroon. PLoS Negl Trop Dis. 2014; 8(7): e2950. PubMed | Google Scholar


7. WHO, Dengue fever, Cape Verde. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations. Weekly epidemiological record/Health Section of the Secretariat of the League of Nations. 2009; 84(45): 469-476.


8. Kuniholm MH, Wolfe ND, Huang CY, Mpoudi-Ngole E, Tamoufe U, LeBreton M et al. Seroprevalence and distribution of Flaviviridae, Togaviridae, and Bunyaviridae arboviral infections in rural Cameroonian adults. Am J Trop Med Hyg. 2006; 74(6): 1078-83. PubMed | Google Scholar


9. Farrar J, Focks D, Gubler D, Barrera R, Guzman MG, Simmons C et al. Towards a global dengue research agenda. Trop Med Int Health. 2007; 12(6): 695-9. PubMed


10. Koum DK, Tsakeu EN, Sack FN, Ngalagou PT, Kamanyi A, Mandengue SH. Clinical and biological aspects of pediatric anemia in a urban district hospital in Cameroon. Pan Afr Med J. 2013; 16: 91. PubMed | Google Scholar


11. Wijedoru L, Mallett S, Parry CM. Rapid diagnostic tests for typhoid and paratyphoid (enteric) fever. Cochrane Database Syst Rev. 2017; 5: CD008892. PubMed | Google Scholar


12. Ammah A, Nkuo-Akenji T, Ndip R, Deas JE. An update on concurrent malaria and typhoid fever in Cameroon. Transacti. 1999; 93(2): 127-9. PubMed | Google Scholar


13. Ali IM, Bigoga JD, Forsah DA, Cho-Ngwa F, Tchinda V, Moor VA et al. Field evaluation of the 22 rapid diagnostic tests for community management of malaria with artemisinin combination therapy in Cameroon. Malar J. 2016; 15: 31. PubMed | Google Scholar


14. Nsutebu EF, Martins P, Adiogo D. Prevalence of typhoid fever in febrile patients with symptoms clinically compatible with typhoid fever in Cameroon. Tropical medicine & international health. 2003; 8(6): 575-8. PubMed | Google Scholar


15. Ahmed S, Arif F, Yahya Y, Rehman A, Abbas K, Ashraf S et al. Dengue fever outbreak in Karachi 2006: a study of profile and outcome of children under 15 years of age. JPMA. 2008; 58(1): 4-8. PubMed | Google Scholar


16. Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, Rothman AL et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet. 2007; 369(9571): 1452-9. PubMed | Google Scholar


17. Assir MZ, Masood MA, Ahmad HI. Concurrent dengue and malaria infection in Lahore, Pakistan during the 2012 dengue outbreak. International journal of infectious diseases. 2014; 18: 41-6. PubMed | Google Scholar


18. Cavalcanti LP, Coelho IC, Vilar DC, Holanda SG, Escossia KN, Souza-Santos R. Clinical and epidemiological characterization of dengue hemorrhagic fever cases in northeastern, Brazil. Rev Soc Bras Med Trop. 2010; 43(4): 355-8. PubMed | Google Scholar


19. Epelboin L, Hanf M, Dussart P, Ouar-Epelboin S, Djossou F, Nacher M et al. Is dengue and malaria co-infection more severe than single infections? A retrospective matched-pair study in French Guiana. Malar J. 2012; 11: 142. PubMed | Google Scholar


20. Halstead SB. Dengue. Lancet. 2007; 370(9599): 1644-52. PubMed


21. Wang SM, Sekaran SD. Early diagnosis of Dengue infection using a commercial Dengue Duo rapid test kit for the detection of NS1, IGM and IGG. Am J Trop Med Hyg. 2010; 83(3): 690-5. PubMed | Google Scholar


22. Dussart P, Petit L, Labeau B, Bremand L, Leduc A, Moua D et al. Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum. PLoS Negl Trop Dis. 2008; 2(8): e280. PubMed | Google Scholar


23. Cochran WG. Sampling Techniques. John Wiley and sons. third edition 1977; pg 442.


24. MINSANTE. Health Analytical Profile 2016, Cameroon, 2017; pg 143.


25. Levine RJ. Some recent developments in the international guidelines on the ethics of research involving human subjects. Annals of the New York Academy of Sciences. 2000; 918: 170-8. PubMed | Google Scholar


26. Nsutebu EF, Ndumbe PM, Koulla S. The increase in occurrence of typhoid fever in Cameroon: overdiagnosis due to misuse of the Widal test. Transacti. 2002; 96(1): 64-7. PubMed | Google Scholar


27. D'Acremont V, Lengeler C, Genton B. Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review. Malar J. 2010; 9: 240. PubMed | Google Scholar


28. Ndo C, Menze-Djantio B, Antonio-Nkondjio C. Awareness, attitudes and prevention of malaria in the cities of Douala and Yaounde (Cameroon). Parasit Vectors. 2011; 4: 181. PubMed | Google Scholar


29. Chukwuma GO, Audu JS, Chukwuma OM, Manafa PO, Ebugosi RS, Akulue JC et al. Seroprevalence of dengue virus among children with febrile illness in Nnewi, Nigeria. J Med Res. 2018; 4(1): 24-30. Google Scholar


30. Onoja AB, Adeniji JA, Olaleye OD. High rate of unrecognized dengue virus infection in parts of the rainforest region of Nigeria. Acta tropica. 2016; 160: 39-43. PubMed | Google Scholar


31. Faneye A, Idika N, Motayo BO, Adesanmi A, Ebele A. Serological evidence of recent dengue virus infection among febrile children in a semi arid zone. Am J Infect Dis. 2013; 9(1): 7-10.


32. WHO. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: WHO Press. 2009; pg 160.


33. Ndip LM, Bouyer DH, Travassos Da Rosa AP, Titanji VP, Tesh RB, Walker DH. Acute spotted fever rickettsiosis among febrile patients, Cameroon. Emerging Infect Dis. 2004; 10(3): 432-7. PubMed | Google Scholar


34. Arragain L, Dupont-Rouzeyrol M, O'Connor O, Sigur N, Grangeon JP, Huguon E et al. Vertical Transmission of Dengue Virus in the Peripartum Period and Viral Kinetics in Newborns and Breast Milk: New Data. J Pediatric Infect Dis Soc. 2017; 6(4): 324-33. PubMed | Google Scholar


35. Arya SC, Agarwal N. Implications of a possible route of vertical transmission of dengue virus by breast milk. J Matern Fetal Neonatal Med. 2014; 27(13): 1394-5 ed. PubMed | Google Scholar


36. Barthel A, Gourinat AC, Cazorla C, Joubert C, Dupont-Rouzeyrol M, Descloux E. Breast milk as a possible route of vertical transmission of dengue virus. Clin Infect Dis. 2013; 57(3): 415-7. PubMed | Google Scholar


37. Rossi SL, Nasar F, Cardosa J, Mayer SV, Tesh RB, Hanley KA et al. Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains. Virology. 2012; 423(1): 58-67. PubMed


38. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010; 8(12 Suppl): S7-16. PubMed | Google Scholar


39. Halstead SB, Sukhavachana P, Nisalak A. In Vitro Recovery of Dengue Viruses from Naturally Infected Human Beings and Arthropods. Nature. 1964; 202: 931-2. PubMed | Google Scholar


40. Simmons CP, Chau TN, Thuy TT, Tuan NM, Hoang DM, Thien NT et al. Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis. 2007; 196(3): 416-24. PubMed | Google Scholar


41. Tsai TF, Lazuick JS, Ngah RW, Mafiamba PC, Quincke G, Monath TP. Investigation of a possible yellow fever epidemic and serosurvey for flavivirus infections in northern Cameroon, 1984. Bulletin of the World Health Organization. 1987; 65(6): 855-60. PubMed | Google Scholar


42. Kamgang B, Brengues C, Fontenille D, Njiokou F, Simard F, Paupy C. Genetic structure of the tiger mosquito, Aedes albopictus, in Cameroon (Central Africa). PloS one. 2011; 6(5): e20257. PubMed | Google Scholar


43. Kamgang B, Nchoutpouen E, Simard F, Paupy C. Notes on the blood-feeding behavior of Aedes albopictus (Diptera: Culicidae) in Cameroon. Parasites & vectors. 2012; 5: 57. PubMed | Google Scholar


44. Kamgang B, Yougang AP, Tchoupo M, Riveron JM, Wondji C. Temporal distribution and insecticide resistance profile of two major arbovirus vectors Aedes aegypti and Aedes albopictus in Yaounde, the capital city of Cameroon. Parasites & vectors. 2017; 10(1): 469. PubMed


45. Paupy C, Brengues C, Kamgang B, Herve JP, Fontenille D, Simard F. Gene flow between domestic and sylvan populations of Aedes aegypti (Diptera: Culicidae) in North Cameroon. J Med Entomol. 2008; 45(3): 391-400. PubMed | Google Scholar


46. Paupy C, Ollomo B, Kamgang B, Moutailler S, Rousset D, Demanou M et al. Comparative role of Aedes albopictus and Aedes aegypti in the emergence of Dengue and Chikungunya in central Africa. Vector Borne Zoonotic Dis. 2010; 10(3): 259-66. PubMed | Google Scholar


47. Vicens R, Robert V, Pignon D, Zeller H, Ghipponi PM, Digoutte JP. Yellow fever epidemic in the extreme North of Cameroon in 1990: first yellow fever virus isolation in Cameroon. Bulletin of the World Health Organization. 1993; 71(2): 173-6. PubMed | Google Scholar


48. Wiysonge CS, Nomo E, Mawo J, Ofal J, Mimbouga J, Ticha J et al. Yellow fever control in Cameroon: where are we now and where are we going. BMC Medicine. 2008; 6: 3. PubMed | Google Scholar